![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SCN7A |
Gene summary for SCN7A |
![]() |
Gene information | Species | Human | Gene symbol | SCN7A | Gene ID | 6332 |
Gene name | sodium voltage-gated channel alpha subunit 7 | |
Gene Alias | NaG | |
Cytomap | 2q24.3 | |
Gene Type | protein-coding | GO ID | GO:0001508 | UniProtAcc | Q01118 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
6332 | SCN7A | P8T-E | Human | Esophagus | ESCC | 2.12e-03 | 2.57e-01 | 0.0889 |
6332 | SCN7A | P9T-E | Human | Esophagus | ESCC | 8.38e-03 | 1.36e-01 | 0.1131 |
6332 | SCN7A | P11T-E | Human | Esophagus | ESCC | 3.66e-11 | 8.26e-01 | 0.1426 |
6332 | SCN7A | P19T-E | Human | Esophagus | ESCC | 2.95e-08 | 1.09e+00 | 0.1662 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Esophagus | ![]() | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias | ||
LGIN: Low-grade intraepithelial neoplasias |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SCN7A | SNV | Missense_Mutation | c.4751G>T | p.Arg1584Ile | p.R1584I | Q01118 | protein_coding | deleterious(0) | possibly_damaging(0.867) | TCGA-CH-5771-01 | Prostate | prostate adenocarcinoma | Male | <65 | 7 | Unknown | Unknown | SD | |
SCN7A | SNV | Missense_Mutation | c.1337N>A | p.Thr446Lys | p.T446K | Q01118 | protein_coding | tolerated(0.38) | benign(0.014) | TCGA-EJ-5507-01 | Prostate | prostate adenocarcinoma | Male | <65 | 9 | Unknown | Unknown | SD | |
SCN7A | SNV | Missense_Mutation | novel | c.2177N>T | p.Ala726Val | p.A726V | Q01118 | protein_coding | deleterious(0) | possibly_damaging(0.666) | TCGA-EJ-5531-01 | Prostate | prostate adenocarcinoma | Male | <65 | 7 | Unknown | Unknown | SD |
SCN7A | SNV | Missense_Mutation | c.3740T>A | p.Val1247Glu | p.V1247E | Q01118 | protein_coding | deleterious(0) | benign(0.333) | TCGA-HI-7171-01 | Prostate | prostate adenocarcinoma | Male | <65 | 9 | Hormone Therapy | casodex | PD | |
SCN7A | SNV | Missense_Mutation | c.4373N>A | p.Pro1458His | p.P1458H | Q01118 | protein_coding | deleterious(0.01) | probably_damaging(1) | TCGA-XK-AAIW-01 | Prostate | prostate adenocarcinoma | Male | >=65 | 9 | Unknown | Unknown | PD | |
SCN7A | SNV | Missense_Mutation | c.521N>T | p.Ser174Phe | p.S174F | Q01118 | protein_coding | deleterious(0) | benign(0.021) | TCGA-ZG-A9M4-01 | Prostate | prostate adenocarcinoma | Male | >=65 | 9 | Unknown | Unknown | SD | |
SCN7A | SNV | Missense_Mutation | c.616N>A | p.Gln206Lys | p.Q206K | Q01118 | protein_coding | tolerated(0.08) | benign(0) | TCGA-BR-8368-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
SCN7A | SNV | Missense_Mutation | c.2581G>T | p.Gly861Cys | p.G861C | Q01118 | protein_coding | deleterious(0.05) | possibly_damaging(0.819) | TCGA-BR-8372-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Chemotherapy | etoposide | CR | |
SCN7A | SNV | Missense_Mutation | c.3436A>G | p.Thr1146Ala | p.T1146A | Q01118 | protein_coding | deleterious(0.01) | benign(0.192) | TCGA-CD-A4MJ-01 | Stomach | stomach adenocarcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | CR | |
SCN7A | SNV | Missense_Mutation | c.1406N>C | p.Lys469Thr | p.K469T | Q01118 | protein_coding | deleterious(0.01) | benign(0.118) | TCGA-CG-4441-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
6332 | SCN7A | ION CHANNEL, DRUGGABLE GENOME | blocker | CHEMBL856 | PRIMIDONE | |
6332 | SCN7A | ION CHANNEL, DRUGGABLE GENOME | blocker | CHEMBL1200440 | MEPIVACAINE HYDROCHLORIDE | |
6332 | SCN7A | ION CHANNEL, DRUGGABLE GENOME | blocker | CHEMBL16 | PHENYTOIN | |
6332 | SCN7A | ION CHANNEL, DRUGGABLE GENOME | blocker | CHEMBL1201020 | DISOPYRAMIDE PHOSPHATE | |
6332 | SCN7A | ION CHANNEL, DRUGGABLE GENOME | blocker | CHEMBL1200464 | PROPARACAINE HYDROCHLORIDE | |
6332 | SCN7A | ION CHANNEL, DRUGGABLE GENOME | blocker | CHEMBL1255654 | TETRACAINE HYDROCHLORIDE | |
6332 | SCN7A | ION CHANNEL, DRUGGABLE GENOME | blocker | CHEMBL1200334 | MORICIZINE HYDROCHLORIDE | |
6332 | SCN7A | ION CHANNEL, DRUGGABLE GENOME | blocker | CHEMBL1889140 | ROPIVACAINE HYDROCHLORIDE | |
6332 | SCN7A | ION CHANNEL, DRUGGABLE GENOME | blocker | CHEMBL87992 | ESLICARBAZEPINE ACETATE | |
6332 | SCN7A | ION CHANNEL, DRUGGABLE GENOME | blocker | CHEMBL944 | CHLOROPROCAINE HYDROCHLORIDE |
Page: 1 2 3 4 5 6 |